129271-98-3 Usage
Uses
Used in Pharmaceutical Industry:
1-(PHENYLSULFONYL)-1H-INDOL-3-YLBORONIC ACID is used as a key intermediate in the synthesis of various pharmaceutical compounds for its ability to form carbon-carbon bonds through chemoselective cross-coupling reactions. This allows for the creation of complex molecular structures that are essential in the development of new drugs with improved efficacy and selectivity.
Used in Organic Synthesis:
In the realm of organic synthesis, 1-(PHENYLSULFONYL)-1H-INDOL-3-YLBORONIC ACID serves as a versatile building block for the construction of a wide range of organic molecules. Its reactivity in cross-coupling reactions enables the formation of new carbon-carbon bonds, which is crucial for the synthesis of complex organic compounds with potential applications in various fields, such as materials science, agrochemicals, and specialty chemicals.
Used in Chemical Research:
1-(PHENYLSULFONYL)-1H-INDOL-3-YLBORONIC ACID is also utilized in academic and industrial research settings for the investigation of new reaction mechanisms, the development of novel synthetic methods, and the exploration of structure-activity relationships in biologically active molecules. Its unique reactivity and selectivity make it a valuable tool for advancing the understanding of organic chemistry and its applications.
Check Digit Verification of cas no
The CAS Registry Mumber 129271-98-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,9,2,7 and 1 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 129271-98:
(8*1)+(7*2)+(6*9)+(5*2)+(4*7)+(3*1)+(2*9)+(1*8)=143
143 % 10 = 3
So 129271-98-3 is a valid CAS Registry Number.
InChI:InChI=1/C14H12BNO4S/c17-15(18)13-10-16(14-9-5-4-8-12(13)14)21(19,20)11-6-2-1-3-7-11/h1-10,17-18H
129271-98-3Relevant articles and documents
FUNCTIONALISED AND SUBSTITUTED INDOLES AS ANTI-CANCER AGENTS
-
Page/Page column 43; 44, (2015/06/08)
The present invention relates to anti-tropomyosin compounds, processes for their preparation, and methods for treating or preventing a proliferative disease, preferably cancer, using compounds of the invention.
Computer-aided rational drug design: A novel agent (SR13668) designed to mimic the unique anticancer mechanisms of dietary indole-3-carbinol to block Akt signaling
Chao, Wan-Ru,Yean, Dawn,Amin, Khalid,Green, Carol,Jong, Ling
, p. 3412 - 3415 (2008/02/11)
Indole-3-carbinol (I3C) is a naturally occurring anticancer agent and has entered clinical trials for cancer prevention. However, the clinical development of I3C has been impeded by its poor metabolic profile. The active components of I3C were used to develop a novel class of indole analogs to optimize I3C's anticancer actions, including blocking growth factor-stimulated Akt activation. The most promising of these analogs, SRI3668, exhibited potent oral anticancer activity against various cancers and no significant toxicity.
HETEROARYL SUBSTITUTED PHENYL ISOXAZOLE SULFONAMIDE ENDOTHELIN ANTAGONISTS
-
, (2008/06/13)
Compounds of the formula STR1 inhibit the activity of endothelin.